New Insight Wealth Advisors’s AbbVie ABBV Stock Holding History

New Insight Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$606K	Sell	2,407 -994	-29%	-$214K	0.18%	68
2026 Q1	$740K	Sell	3,401 -489	-13%	-$108K	0.27%	58
2025 Q4	$889K	Sell	3,890 -201	-5%	-$45.8K	0.32%	55
2025 Q3	$947K	Sell	4,091 -37	-0.9%	-$7.54K	0.36%	50
2025 Q2	$766K	Sell	4,128 -16	-0.4%	-$2.97K	0.32%	47
2025 Q1	$868K	Buy	4,144 +84	+2%	+$16.3K	0.39%	42
2024 Q4	$721K	Sell	4,060 -508	-11%	-$93.4K	0.36%	41
2024 Q3	$902K	Sell	4,568 -362	-7%	-$67.6K	0.47%	35
2024 Q2	$846K	Sell	4,930 -660	-12%	-$109K	0.5%	36
2024 Q1	$1.02M	Sell	5,590 -57	-1%	-$9.82K	0.64%	31
2023 Q4	$875K	Buy	+5,647	New	+$823K	0.59%	35

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

New Insight Wealth Advisors's ABBV Position: Q2 2026 in Review

New Insight Wealth Advisors reduced its AbbVie (ABBV) stake by 29% in Q2 2026, selling an estimated $214K and leaving 2,407 shares worth $606K. The position accounts for 0.18% of the portfolio, ranked #68.

New Insight Wealth Advisors first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.02M in Q1 2024. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

New Insight Wealth Advisors held 2,407 shares of AbbVie worth $606K as of Q2 2026.
New Insight Wealth Advisors sold 994 AbbVie shares in Q2 2026, an estimated $214K.
AbbVie made up 0.18% of New Insight Wealth Advisors's portfolio in Q2 2026, its #68 holding.
New Insight Wealth Advisors first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
New Insight Wealth Advisors's AbbVie position peaked at $1.02M in Q1 2024.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on New Insight Wealth Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.